Does RAMUCIRUMAB Cause Off label use? 148 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Off label use have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 2.8% of all adverse event reports for RAMUCIRUMAB.
148
Reports of Off label use with RAMUCIRUMAB
2.8%
of all RAMUCIRUMAB reports
30
Deaths
49
Hospitalizations
How Dangerous Is Off label use From RAMUCIRUMAB?
Of the 148 reports, 30 (20.3%) resulted in death, 49 (33.1%) required hospitalization, and 10 (6.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMUCIRUMAB. However, 148 reports have been filed with the FAERS database.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Interstitial lung disease (269)
Febrile neutropenia (229)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RAMUCIRUMAB Alternatives Have Lower Off label use Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE